Under eller efter infusion med rituximab kan der opstå alvorlige infusionsreaktioner, som kan omfatte smerte i brystet, kardiogent shock, myokardieinfarkt, pulmonært ødem, ventrikulær fibrillation, apnø, bronkospasme, dyspnø, hypoksi, angioneurotisk ødem, rødmen, hypotension, ARDS og lungeinfiltration.
Severe infusion reactions may occur during or following rituximab infusion, which may be associated with chest pain, cardiogenic shock, myocardial infarction, pulmonary edema, ventricular fibrillation, apnea, bronchospasm, dyspnea, hypoxia, angioneurotic edema, flushing, hypotension, ARDS, and lung infiltration.